Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results>HENGRUI PHARMA 2025 NP Surges 21.7% to RMB7.711B; Final Div. RMB20 Cents
Recommend 5 Positive 5 Negative 2 |
||||
|
||||
|
HENGRUI PHARMA (01276.HK) has announced its annual results for the year ended December 2025. The company's turnover rose by 13% YoY to RMB31.629 billion, while net profit surged by 21.7% YoY to RMB7.711 billion, with EPS at RMB1.19. A final dividend of RMB2 per 10 shares was declared. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
